Journals / Türk Patoloji Dergisi / 2011 / Cilt: 27 - Sayı: 3

Hepatektomi ve hepatosellüler karsinom olgularının genel değerlendirilmesi

General evaluation of hepatectomy and hepatocellular carcinoma cases

Pages
221–229
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mean age was 55 and the median age 56.7.Conclusion: The results of this study demonstrated that the most common hepatic disorder was cirrhosis due to Hepatitis B virus in the hepatectomy specimens of our series that mostly consisted of total hepatectomies performed for transplantation where 50% had hepatocellular carcinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Although the clinical and histopathological findings of hepatocellular carcinoma are well described, there are few national studies.
📊
Key Findings & Data:Material and Method: We first collected 190 cases of total or partial hepatectomies performed because of hepatocellular carcinoma, cirrhosis or other disorders from the archives of Pathology.
💡
Conclusion & Impact:The mean age was 55 and the median age 56.7.Conclusion: The results of this study demonstrated that the most common hepatic disorder was cirrhosis due to Hepatitis B virus in the hepatectomy specimens of our series that mostly consisted of total hepatectomies performed for transplantation where 50% had hepatocellular carcinoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Although the clinical and histopathological findings of hepatocellular carcinoma are well described, there are few national studies. In this study, we aimed to investigate the relationship between these findings in total or partial hepatectomy specimens in our series. Material and Method: We first collected 190 cases of total or partial hepatectomies performed because of hepatocellular carcinoma, cirrhosis or other disorders from the archives of Pathology. After re-examining the histopathological and clinical features such as age, gender and etiology, the relationship between them and serology results were statistically analyzed using the chi square and Multiple Comparison Tests.Results: Among 190 cases, there were 168 (88.5%) total and 18 (9.5%) partial hepatectomies and 4 (2%) tumorectomy or metastasectomy cases. After gross and microscopic examination, 170 (89.5%) cases had a diagnosis of cirrhosis, 85 (44.7%) hepatocellular carcinoma, 3 parasitic cyst, 7 metastasis, 1 hepatoblastoma, 1 hepatocellular adenoma, 2 cholangiocarcinoma, 2 Budd Chiari Syndrome, 1 focal nodular hyperplasia, 1 cavernous hemangioma, and 2 acute fulminant hepatitis.Among the hepatocellular carcinoma cases, 53 had Hepatitis B virus, 15 Hepatitis C virus , 3 Hepatitis B virus and Hepatitis C virus, and 3 Hepatitis B virus and Hepatitis delta virus etiology, while 6 were alcoholic and 4 were due to other causes. Among cirrhosis patients, 84 (49.4%) had hepatocellular carcinoma. The male to female ratio of hepatocellular carcinoma cases was 74/11. The mean age was 55 and the median age 56.7.Conclusion: The results of this study demonstrated that the most common hepatic disorder was cirrhosis due to Hepatitis B virus in the hepatectomy specimens of our series that mostly consisted of total hepatectomies performed for transplantation where 50% had hepatocellular carcinoma.

Özet

Amaç: Hepatosellüler karsinomların klinik ve histopatolojik özellikleri iyi tanımlanmış olmakla birlikte ülkemizdeki bulgularını yansıtan araştırma azdır. Bu çalışmada, bölümümüzdeki total ve parsiyel hepatektomi piyeslerinde klinik ve histopatolojik özellikler arasındaki ilişkiyi araştırmak amaçlanmıştır. Gereç ve Yöntem: İlk olarak, hepatosellüler karsinom, siroz veya diğer karaciğer hastalıkları nedeniyle yapılmış 190 olguya ait total (transplantasyon) ve parsiyel hepatektomi materyalleri patoloji arşivinden toplandı. Yeniden değerlendirilen histopatolojik özellikler ile yaş, cinsiyet, etiyoloji gibi klinik ve serolojik bulgular arasındaki ilişki, istatistiksel olarak ki kare ve çok değişkenli korelasyon testi ile araştırıldı.Bulgular: Toplam 190 olgunun 168'ini (%88.5) total, 18'ini (%9.5) parsiyel hepatektomi ve 4'ünü (%2) ise tümörektomi ile metastazektomi materyalleri oluşturmaktaydı. Makroskopik ve mikroskopik incelemelerden sonra 170 olgu (%89.5) siroz tanısı alırken; 85 (%44.7) hepatosellüler karsinom, 1 hepatoblastom, 1 hepatosellüler adenom, 2 kolanjiokarsinom, 3 paraziter kist, 7 tümör metastazı, 2 Budd Chiari sendromu, 1 fokal noduler hiperplazi, 1 kavernöz hemangiom, 2 akut fulminant hepatit saptandı.Hepatosellüler karsinom saptanan siroz olgularının 53'ünde Hepatit B virüsü, 15'inde Hepatit C virüsü, 3'ünde her iki virüs birlikteliği, 3'ünde Hepatit B virüsü ve Hepatit delta virüsü birlikteliği, 6'sında alkol, 4'ünde diğer etiyolojik nedenler izlendi. Siroz olgularının 84'ünde (%49.4) hepatosellüler karsinom saptandı. Hepatosellüler karsinom olgularında erkek kadın oranı 74/11, ortalama yaş 56.7, ortanca yaş 55 idi.Sonuç: Bu çalışmanın sonuçları, transplantasyon amacıyla yapılan total hepatektomilerden oluşan serimizde, en sık hepatik hastalığın Hepatit B virüsüne bağlı siroz olduğunu göstermektedir ve bunların %50' sinde hepatosellüler karsinom mevcuttur.

🔖

Cite This Article

AKYILDIZ, M., BAŞSÜLLÜ, N., DAYANGAÇ, M., GÜLER, N., DEMİRBAŞ, T., TÜRKMEN, İ., CİĞERCİOĞULLARI, E., BÜLBÜL, G. D., YÜZER, Y., YAPRAK, O., URAZ, S., TOKAT, Y. (2022). Hepatektomi ve hepatosellüler karsinom olgularının genel değerlendirilmesi. Türk Patoloji Dergisi, Cilt: 27 - Sayı: 3, 221–229. https://ajindex.com/articles/640760

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Parkin M, Pisani P, Ferlay J: Estimates of the world wide incidence of 25 major cancers in 1990. Int J Cancer 1999, 80: 827-841 [ PubMed ] 2) Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M: Cancer Incidence in Five Continents. Vol. IX, IARC Scientific Publications No. 160, Lyon, IARC, 2007 3) Uzunalimoglu O, Yurdaydin C, Cetinkaya H, Bozkaya H, Sahin T, Colakoglu S, Tankut E, Sarioğlu M, Ozenirler S, Akkiz H, Tozun N, Degertekin H, Okten A: Risk factors for Hepatocellular Carcinoma in Turkey. Dig Dis Sci 2001, 46: 1022–1028 [ PubMed ] 4) Ozer B, Serin E, Yilmaz U, Gumurdulu Y, Saygili BO, Kayaselcuk F, Boyacioglu S: Clinicopathologic features and risk factors for Hepatocellular Carcinoma: Results from a single center in southern Turkey. Turk J Gastroenterol 2003, 14: 85-90 [ PubMed ] 5) Alacacioğlu A, Somali I, Simsek I, Astarcioğlu I, Ozkan M, Camci C, Alkis N, Karaoglu A, Tarhan O, Unek T, Yilmaz U: Epidemiology and survival of Hepatocellular Carcinoma in Turkey: Outcome of multicenter study. Jpn J Clin Oncol 2008, 38:683–688 [ PubMed ] 6) Ökten A: Türkiye'de kronik hepatit, siroz ve hepatosellüler karsinoma etiyolojisi. Güncel Gastroenterol 2003, 7:187-191 7) Allam N, Khalaf H, Fagih M, Al-Sebayel M: Liver transplant for hepatocellular carcinoma: Experience in a Saudi population. Exp Clin Transplant 2008, 6:14-24 [ PubMed ] 8) Shetty K, Timmins K, Bresinger C, Furt EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM: Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predict in outcome. Liver Transpl 2004, 10: 911–918 [ PubMed ] 9) Mazzaferdo V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small Hepatocellular Carcinomas in patients with cirrhosis. N Eng J Med 1996, 334: 693-699 [ PubMed ] 10) Li J, Yan LN, Yang J, Chen ZY, Li B, Zeng Y, Wen TF, Zhao JC, Wang WT, Yang JY, Xu MQ, Ma YK: Indicators of prognosis after liver transplantation in Chinese Hepatocellular Carcinoma patients. World J Gastroenterol 2009, 15: 4170-4176 [ PubMed ] 11) Eser S, Olcayto E, Karakilinç H, Karaoğlanoğlu O, Yakut C, Ozalan S, Uçuncu N, Anbarcioğlu Z, Ergün A, Akin Ü, Yazici M,Ozdemir R, Ozgul N, Tuncer M: Sağlık Bakanlığı Kanserle Savaş Dairesi Başkanlığı, Epidemiyoloji ve Koruma Şube Müdürlüğü, 2004-2006 yılları Türkiye kanser insidansı. Erişim: [ Tam Metin ] 12) Ruby SG: Protocol for the examina